Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3933 Surufatinib plus Sintilimab and IBI310 in patients with high-grade advanced-neuroendocrine neoplasm (HG-NEN): A multicenter, single arm phase 2 study

Introduction: Surufatinib (SUR, a selective VEGFRs, FGFR1 and CSF-1R inhibitor). Preclinical and clinical studies have shown that SUR is the best partner of immune checkpoint inhibitors (ICI).

Conference:

Presenting Author: Zhang P

Authors: Zhang P, Wang Y, Li J, Shen L, Lu M,

Keywords: Surufatinib, Sintilimab, IBI310, high-grade advanced-neuroendocrine neoplasm,